BamSEC and AlphaSense Join Forces
Learn More

Protagonist Therapeutics Inc.

NASDAQ: PTGX    
Share price (1/3/25): $39.57    
Market cap (1/3/25): $2.358 billion

Underwriting Agreements Filter

EX-1.1
from 8-K 46 pages 5,000,000 Shares Protagonist Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.2
from S-3 37 pages Protagonist Therapeutics, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.00001 Per Share (The “Common Shares”), Having an Aggregate Offering Price of Up to $100,000,000 on the Terms Set Forth in This Agreement (This “Agreement”). Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings
12/34/56
EX-1.1
from 8-K 46 pages 3,046,358 Shares Protagonist Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A ~1 page Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 44 pages 4,761,904 Shares Protagonist Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages Protagonist Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1
from SC 13G 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 38 pages Protagonist Therapeutics, Inc. (A Delaware Corporation) 3,530,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3 44 pages Protagonist Therapeutics, Inc. Shares of Common Stock (Par Value $0.00001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from S-1/A 39 pages Protagonist Therapeutics, Inc. (A Delaware Corporation) [●] Shares of Common Stock Underwriting Agreement
12/34/56